Izrailit et al. [21] have reported that TRIB3 was a master regulator of Notch through the mitogen activated protein kinase (MAPK)-extracellular signal–regulated kinase (ERK) and TGF-β pathways in breast cancer cells. Here, TRIB3 is linked to breast carcinoma.